무균 검사 시장 규모 : 제품 유형별, 용도별, 지역별, 범위 및 예측

Sterility Testing Market Size And Forecast

Sterility Testing Market size was valued at USD 1.43 Billion in 2024 and is projected to reach USD 3.36 Billion by 2031 , growing at a CAGR of 12.40% from 2024 to 2031. Sterility testing is defined as a process used to determine the presence or absence of viable microorganisms in pharmaceutical products, medical devices, and other healthcare-related items. This testing is crucial for ensuring the safety and efficacy of products before they are released for human use. Furthermore, sterility testing is commonly employed in the pharmaceutical industry, biotechnology sector, and medical device manufacturing to comply with regulatory requirements and maintain product quality.

Sterility Testing Market Dynamics

The key market dynamics that are shaping the sterility testing market include:

Key Market Drivers

Increasing Pharmaceutical and Biotechnology Production

: The global rise in pharmaceutical and biotechnology manufacturing, particularly for sterile drug products, is a significant driver of the sterility testing industry. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reports that the worldwide biopharmaceutical business was worth $1.5 trillion in 2022. The rising demand for sterile biologics and vaccines has increased the requirement for sterility testing to ensure product safety and regulatory compliance.

Growing Number of Regulatory Requirements for Sterile Drug Approval

: Stringent regulatory requirements for the production and approval of sterile medications are driving firms to use sterility testing. The United States Food and Drug Administration (FDA) requires that any new sterile drug product pass sterility testing as part of the clearance procedure. In 2021, the FDA authorized 50 novel molecular entities, many of which required significant sterility testing, resulting in market growth.

Rising Demand for Cell and Gene Therapies

: The growing use of sophisticated medicines like cell and gene therapy has increased the necessity for sterility testing. According to a Report, more than 2,500 clinical studies for cell and gene therapies will be conducted worldwide in 2022. These therapies must go through thorough sterility testing to meet quality and safety regulations, which contributes significantly to the sterility testing market's growth.

Key Challenges

High Costs Associated with Sterility Testing:

The costs associated with sterility testing equipment, consumables, and skilled personnel are being considered high. This factor is potentially limiting market growth, especially among smaller companies and in developing regions.

Time-Consuming Nature of Traditional Methods:

Traditional sterility testing methods are often time-consuming, which delays product release. This challenge is being addressed through the development of rapid sterility testing methods, but their adoption is still limited.

Risk of False Positives and Negatives:

Sterility testing methods sometimes produce false positive or false negative results, which have significant implications for product quality and safety. Overcoming this challenge is being seen as crucial for improving the reliability of sterility testing.

Key Trends

Adoption of Rapid Microbial Methods:

There is a growing trend towards the adoption of rapid microbial methods (RMM) for sterility testing. These methods are being developed to provide faster results while maintaining or improving accuracy compared to traditional methods.

Increasing Outsourcing of Sterility Testing:

Many pharmaceutical and biotechnology companies are outsourcing their sterility testing to specialized contract testing laboratories. This trend is being driven by the need for expertise, advanced technologies, and cost efficiencies.

Integration of Automation and Robotics:

Automation and robotics are increasingly being integrated into sterility testing processes. These technologies are helping to reduce human error, increase throughput, and improve the overall efficiency of sterility testing procedures.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Sterility Testing Market Regional Analysis

The regional analysis of the sterility testing market is provided below:

North America

According to Verified Market Research, North America is estimated to dominate the sterility testing market over the forecast period. North America, particularly the U.S., is a leader in biopharmaceutical and vaccine production, driving the demand for sterility testing to ensure product safety. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. biopharmaceutical companies spent nearly $102.3 billion on research and development in 2021, accounting for over 40% of the global pharmaceutical market. This significant production and investment necessitate extensive sterility testing to meet stringent regulatory standards.

The U.S. Food and Drug Administration (FDA) enforces rigorous sterility testing guidelines for sterile pharmaceuticals and biologics. In 2021, the FDA approved 50 new molecular entities, many of which required sterility testing as part of the drug approval process. The strict regulatory landscape in North America ensures that sterility testing is a crucial component of pharmaceutical development, significantly boosting market growth in the region.

Furthermore, North America is at the forefront of cell and gene therapy development, which requires intensive sterility testing to ensure product safety. According to the Alliance for Regenerative Medicine, 92 gene and cell therapies were in late-stage clinical trials in the U.S. by the end of 2021. As these advanced therapies gain approval and commercialization, the demand for sterility testing in the region continues to rise, driving market expansion.

Europe

The Europe region is expected to exhibit the highest growth rate during the forecast period. Europe is home to thriving pharmaceutical and biopharmaceutical manufacturing sectors, driving the demand for sterility testing to ensure compliance with quality standards. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), Europe accounted for 23.9% of global pharmaceutical sales in 2022, with a focus on sterile drug products, biologics, and vaccines. This strong production capacity creates a consistent demand for sterility testing across the region.

European regulatory agencies, such as the European Medicines Agency (EMA), enforce strict guidelines for sterility testing to ensure the safety and efficacy of pharmaceuticals. In 2021, the EMA approved 92 new medicines, many of which included sterile biologics and vaccines that require rigorous sterility testing. These stringent regulatory requirements are driving the adoption of sterility testing across pharmaceutical manufacturing in Europe.

Furthermore, Europe is a leader in the research and development of advanced therapies such as cell and gene therapy, which necessitate thorough sterility testing. According to a Report, Europe accounted for 23% of global clinical trials for cell and gene therapies. As these therapies move through clinical trials and into commercialization, the demand for sterility testing to meet safety standards is driving market growth in the region.

Sterility Testing Market: Segmentation Analysis

The Global Sterility Testing Market is being segmented based on Product, Test Type, Application, and Geography.

Sterility Testing Market, By Product

• Kits & Reagents
• Instruments
• Services

Based on Product, the market is segmented into Kits & Reagents, Instruments, and Services. The kits & reagents segment is estimated to dominate the market over the forecast period. This dominance is attributed to the frequent and recurring use of these products in sterility testing procedures. The increasing demand for ready-to-use sterility testing kits and the growing emphasis on quality control in the pharmaceutical and biotechnology industries are further driving the growth of this segment.

Sterility Testing Market, By Test Type

• Membrane Filtration
• Direct Inoculation
• Others

Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation, and Others. The membrane filtration segment is projected to hold the largest market share during the forecast period. This method is preferred due to its high sensitivity and ability to test large sample volumes. It is particularly suited for testing water-soluble products, which is contributing to its widespread adoption in the pharmaceutical industry.

Sterility Testing Market, By Application

• Pharmaceutical & Biological Manufacturing
• Medical Devices Manufacturing
• Others

Based on Application, the market is segmented into Pharmaceutical & Biological Manufacturing, Medical Devices Manufacturing, and Others. The pharmaceutical & biological manufacturing segment is estimated to dominate the market. This dominance is being attributed to the stringent regulatory requirements for ensuring the sterility of pharmaceutical and biological products, the increasing production of biologics and biosimilars, and the growing focus on quality assurance in drug manufacturing.

Sterility Testing Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the sterility testing market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate the market during the forecast period. This dominance is attributed to the presence of a well-established pharmaceutical and biotechnology industry, stringent regulatory standards, and high adoption of advanced sterility testing technologies in the region.

Key Players

• The "Sterility Testing Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Charles River Laboratories, Merck KGaA, Thermo Fisher Scientific, bioMerieux SA, SGS SA, Sartorius AG, WuXi AppTec, Becton, Dickinson and Company, Nelson Laboratories, LLC, and Eurofins Scientific.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Sterility Testing Market Recent Developments
• In December 2023, Charles River Laboratories announced the expansion of its sterility testing capabilities in Europe with the opening of a new facility in Ireland, aimed at meeting the growing demand for these services in the region.
• In October 2023, Merck KGaA launched a new rapid sterility testing kit that promises to deliver results in half the time of traditional methods, addressing the industry's need for faster product release.
• In August 2023, Thermo Fisher Scientific introduced an automated sterility testing system that integrates robotics and advanced analytics, aimed at improving efficiency and reducing human error in sterility testing procedures.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STERILITY TESTING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STERILITY TESTING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STERILITY TESTING MARKET, BY TYPE

• 5.1 Overview
• 5.2 Kits & Reagents
• 5.3 Consumables
• 5.4 Biomedical Instruments
• 5.5 Services.

6 GLOBAL STERILITY TESTING MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pharmaceutical Companies
• 6.3 Hospitals
• 6.4 Pathological Laboratories
• 6.5 Academic Laboratories
• 6.6 Others

7 GLOBAL STERILITY TESTING MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL STERILITY TESTING MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Danaher Corporation
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Pace Analytical Serv.
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Boston Analytical
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Toxicon Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Merck KGaA
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Thermo Fisher Scientific Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Development
• 9.7 SGS SA
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Biomerieux SA
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Nelson Laboratories
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Development
• 9.10 Charles River Laboratories International, Inc.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Development

10 Appendix

• 10.1.1 Related Reports